UA84591C2 - Process for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide - Google Patents
Process for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamideInfo
- Publication number
- UA84591C2 UA84591C2 UAA200609080A UAA200609080A UA84591C2 UA 84591 C2 UA84591 C2 UA 84591C2 UA A200609080 A UAA200609080 A UA A200609080A UA A200609080 A UAA200609080 A UA A200609080A UA 84591 C2 UA84591 C2 UA 84591C2
- Authority
- UA
- Ukraine
- Prior art keywords
- oxo
- oxazolidine
- morpholinyl
- chloro
- phenyl
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The invention relates to a method for producing 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide from 2-[(2S)-2-oxiranylmethyl]-1H-isoindol-1,3(2H)-dione, 4-(4-aminophenyl)-3-morpholinone, and 5-chlorothiophene-2-carbonyl chloride.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA200609080A UA84591C2 (en) | 2004-12-31 | 2004-12-31 | Process for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAA200609080A UA84591C2 (en) | 2004-12-31 | 2004-12-31 | Process for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
Publications (1)
Publication Number | Publication Date |
---|---|
UA84591C2 true UA84591C2 (en) | 2008-11-10 |
Family
ID=50180789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA200609080A UA84591C2 (en) | 2004-12-31 | 2004-12-31 | Process for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA84591C2 (en) |
-
2004
- 2004-12-31 UA UAA200609080A patent/UA84591C2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY138944A (en) | Preparation process | |
WO2005060940A3 (en) | Method for the production of a solid, orally applicable pharmaceutical composition | |
HK1125103A1 (en) | Polymorphous form and the amorphous form of 5-chloro-n-({ (5s)-2-oxo-3-[4- (3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide | |
AU2003296728A1 (en) | Method for producing 5-chloro-n-({5s)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidin-5-yl}-methyl)-2-thiophene carboxamide | |
MY143999A (en) | Solid, modified-release pharmaceutical dosage forms which can be administered orally | |
WO2007039122A3 (en) | Solid orally administerable pharmaceutical dosage forms with rapid active principle release | |
HK1130252A1 (en) | Aminoacyl prodrug derivatives and medicaments for the treatment of thromboembolitic disorders | |
ZA200802871B (en) | Novel polymorphous form and the amorphous form of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide | |
ATE545645T1 (en) | NEW COCRYSTAL COMPOUND OF RIVAROXABAN AND MALONIC ACID | |
UA84591C2 (en) | Process for the preparation of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide | |
UA94428C2 (en) | Polymorphous form and the amorphous form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide | |
DOP2004001066A (en) | PREPARATION PROCEDURE | |
CU23445A3 (en) | PREPARATION PROCEDURE | |
TH79777B (en) | Preparation process | |
TH145210A (en) | Process for the Preparation of A solid, Orally Adminnistrable Pharmaceutical Composition | |
DOP2004001034A (en) | PROCEDURE FOR THE PREPARATION OF A SOLID ADMINISTRABLE PHARMACEUTICAL COMPOSITION ORALALLY INCLUDING 5-CHLORINE-N - ({(5S) -2-OXO-3- [4- (3-OXO-4-MORFOLINIL) -FENIL] -1,3 -OXAZOLIDIN-5-IL} -METIL) -2-THIOFENCARBOXAMIDE IN HYDROPHILIZED FORM |